Early Access — free while we kick the tires
EdgarHawk

SCHWAB SUSAN C

Director

Director

Latest: Director selling · April 2026

2 filings analyzed · 1 company · Latest 2026-04-16

Companies

Company Buys Sells Direction
FEDEX CORP FDX 0 5 Net selling

Activity

April 2026
2026-04-16 FEDEX CORP FDX
high
Sell
5,795 shares
$2,138,355
Significance 6/10

Director SCHWAB SUSAN C sold 5,795 FDX shares at $369.00 on 2026-04-15 ($2.1M), reducing stake by 36.6% to 10.0K shares.

Director Susan C. Schwab sold 5,795 shares of FedEx at $369.00 on 2026-04-15, reducing her holdings from 15,833 shares to 10,038 shares (a 36.6% reduction). The sale occurred near the 52-week high at -2.0% from the peak of $388.48, and notably both of Schwab's prior FedEx sales (2025-01-14 and 2024-03-27) were well-timed at the 90-day mark, with the earlier trade followed by a -23.9% decline. Across her full cross-ticker transaction history, her prior 2 sells carried a 100.00% well-timed rate at 90 days, though the small sample size and recent strong momentum (+7.4% over 30 days, +23.6% over 90 days) create uncertainty about predictive value. FedEx fundamentals show modest growth (revenue +0.3% year-over-year) with a P/E of 20.27, suggesting the stock is fairly valued but not on a strong secular trajectory, which may contextualize a substantial stake reduction by a board member.

January 2025
2025-01-14 FEDEX CORP FDX
medium
Sell
3,980 shares
$1,100,257
Significance 6/10

Director Schwab sells 3,980 FDX shares at $276.45 (January 14, 2025); cross-ticker track record shows 100% well-timed sell pattern

Director Susan C Schwab sold 3,980 shares of FDX at $276.45 on 2025-01-14, reducing her holdings by -30.9%. Her cross-ticker track record across all open-market sells shows a 100.00% well-timed rate, meaning prior sales preceded declines in the 90-day window. While this insider has demonstrated consistent sell timing across multiple securities (prior 90-day return of -11.0%), her single prior FDX trade at this ticker in March 2024 also aligned with subsequent weakness (90-day return -11.0%). The current price of $277.62 sits -11.4% from the 52-week high and only +2.1% over 90 days, suggesting the stock has already retraced much of prior momentum. The sale's significance is tempered by FDX's stable fundamentals: $22.0B quarterly revenue, P/E of 17.20, and market cap of $66.9B, indicating no underlying distress signal at the company level.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access